BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 31420082)

  • 1. Pregnancy exposure to disease-modifying drugs in multiple sclerosis: a prospective study.
    Cuello JP; Salgado Cámara P; García Domínguez JM; Lozano Ros A; Mas Serrano M; Martínez Ginés ML
    Med Clin (Barc); 2020 Mar; 154(6):214-217. PubMed ID: 31420082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-beta exposure during first trimester is safe in women with multiple sclerosis-A prospective cohort study from the German Multiple Sclerosis and Pregnancy Registry.
    Thiel S; Langer-Gould A; Rockhoff M; Haghikia A; Queisser-Wahrendorf A; Gold R; Hellwig K
    Mult Scler; 2016 May; 22(6):801-9. PubMed ID: 26920382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glatiramer acetate during early pregnancy: A prospective cohort study.
    Herbstritt S; Langer-Gould A; Rockhoff M; Haghikia A; Queisser-Wahrendorf A; Gold R; Hellwig K
    Mult Scler; 2016 May; 22(6):810-6. PubMed ID: 26754804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paternal therapy with disease modifying drugs in multiple sclerosis and pregnancy outcomes: a prospective observational multicentric study.
    Pecori C; Giannini M; Portaccio E; Ghezzi A; Hakiki B; Pastò L; Razzolini L; Sturchio A; De Giglio L; Pozzilli C; Paolicelli D; Trojano M; Marrosu MG; Patti F; Mancardi GL; Solaro C; Totaro R; Tola MR; De Luca G; Lugaresi A; Moiola L; Martinelli V; Comi G; Amato MP;
    BMC Neurol; 2014 May; 14():114. PubMed ID: 24884599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregnancy outcomes after early fetal exposure to injectable first-line treatments, dimethyl fumarate, or natalizumab in Danish women with multiple sclerosis.
    Andersen JB; Sellebjerg F; Magyari M
    Eur J Neurol; 2023 Jan; 30(1):162-171. PubMed ID: 36098960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perinatal outcomes in women with multiple sclerosis exposed to disease-modifying drugs.
    Lu E; Dahlgren L; Sadovnick A; Sayao A; Synnes A; Tremlett H
    Mult Scler; 2012 Apr; 18(4):460-7. PubMed ID: 21914689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term effects of exposure to disease-modifying drugs in the offspring of mothers with multiple sclerosis: a retrospective chart review.
    Fragoso YD; Adoni T; Alves-Leon SV; Azambuja ND; Barreira AA; Brooks JB; Carneiro DS; Carvalho MJ; Claudino R; Comini-Frota ER; Domingues RB; Finkelzstejn A; Gama PD; Giacomo MC; Gomes S; Goncalves MV; Grzesiuk AK; Kaimen-Maciel DR; Mendes MF; Morales NM; Morales RR; Muniz A; Papais-Alvarenga RM; Parolin MK; Ribeiro SB; Ruocco HH; Siquineli F; Tosta ED
    CNS Drugs; 2013 Nov; 27(11):955-61. PubMed ID: 24114585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiological characteristics of pregnancy, delivery, and birth outcome in women with multiple sclerosis in Argentina (EMEMAR study).
    Fernández Liguori N; Klajn D; Acion L; Cáceres F; Calle A; Carrá A; Cristiano E; Deri N; Garcea O; Jaureguiberry A; Onaha P; Patrucco L; Riccio P; Rotta Escalante R; Saladino Ml; Sinay V; Tarulla A; Villa A
    Mult Scler; 2009 May; 15(5):555-62. PubMed ID: 19299437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics and outcomes in pregnant women with epilepsy.
    Huang CY; Dai YM; Feng LM; Gao WL
    Epilepsy Behav; 2020 Nov; 112():107433. PubMed ID: 32919204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple sclerosis and pregnancy: a single-centre prospective comparative study.
    Cuello JP; Martínez Ginés ML; Martin Barriga ML; de Andrés C
    Neurologia; 2017 Mar; 32(2):92-98. PubMed ID: 25728948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disease Progression and Obstetric Outcomes of Women with Multiple Sclerosis at a Reference Center in Northeastern Brazil.
    Barros GMC; Oliveira BES; Oliveira GJ; Silva RKP; Cardoso TN; Maia SB
    Rev Bras Ginecol Obstet; 2021 Mar; 43(3):165-171. PubMed ID: 33860499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple sclerosis: management issues during pregnancy.
    Ferrero S; Pretta S; Ragni N
    Eur J Obstet Gynecol Reprod Biol; 2004 Jul; 115(1):3-9. PubMed ID: 15223156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association between exposure to interferon-beta during pregnancy and birth measurements in offspring of women with multiple sclerosis.
    Burkill S; Vattulainen P; Geissbuehler Y; Sabido Espin M; Popescu C; Suzart-Woischnik K; Hillert J; Artama M; Verkkoniemi-Ahola A; Myhr KM; Cnattingius S; Korhonen P; Montgomery S; Bahmanyar S
    PLoS One; 2019; 14(12):e0227120. PubMed ID: 31887199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregnancy outcome and factors affecting vaginal delivery of twins at University of Nigeria Teaching Hospital, Enugu.
    Nwankwo TO; Aniebue UU; Ezenkwele E; Nwafor MI
    Niger J Clin Pract; 2013; 16(4):490-5. PubMed ID: 23974745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use and safety of disease-modifying therapy in pregnant women with multiple sclerosis.
    MacDonald SC; McElrath TF; Hernández-Díaz S
    Pharmacoepidemiol Drug Saf; 2019 Apr; 28(4):556-560. PubMed ID: 30834654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of long-term exposure to disease-modifying drugs during pregnancy in multiple sclerosis.
    Fragoso YD; Boggild M; Macias-Islas MA; Carra A; Schaerer KD; Aguayo A; de Almeida SM; Alvarenga MP; Alvarenga RM; Alves-Leon SV; Arruda WO; Brooks JB; Comini-Frota ER; Ferreira ML; Finkelsztejn A; Finkelsztejn JM; de Freitas LD; Gallina AS; da Gama PD; Georgetto S; Giacomo MC; Gomes S; Gonçalves MV; Grzesiuk AK; Kaimen-Maciel DR; Lopes J; Lourenco GA; Malfetano FR; Morales NM; Morales Rde R; Oliveira CL; Onaha P; Patroclo C; Ribeiro SB; Ribeiro TA; Salminen HJ; Santoro P; Seefeld M; Soares PV; Tarulla A; Vasconcelos CC
    Clin Neurol Neurosurg; 2013 Feb; 115(2):154-9. PubMed ID: 22633835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Multiple sclerosis and childbirth: Relapse frequency and pregnancy outcome. A hospital-based retrospective study].
    Bergthorsdóttir BB; Thorhallsdottir RL; Steingrimsdottir T; Hjaltason H
    Laeknabladid; 2020 Desember; 106(12):581-589. PubMed ID: 33252050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pregnancy and fetal outcomes after Glatiramer Acetate exposure in patients with multiple sclerosis: a prospective observational multicentric study.
    Giannini M; Portaccio E; Ghezzi A; Hakiki B; Pastò L; Razzolini L; Piscolla E; De Giglio L; Pozzilli C; Paolicelli D; Trojano M; Marrosu MG; Patti F; La Mantia L; Mancardi G; Solaro C; Totaro R; Tola MR; De Luca G; Lugaresi A; Moiola L; Martinelli V; Comi G; Amato MP
    BMC Neurol; 2012 Oct; 12():124. PubMed ID: 23088447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systematic review and meta-analyses of pregnancy and fetal outcomes in women with multiple sclerosis: a contribution from the IMI2 ConcePTION project.
    Lopez-Leon S; Geissbühler Y; Sabidó M; Turkson M; Wahlich C; Morris JK
    J Neurol; 2020 Sep; 267(9):2721-2731. PubMed ID: 32444984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Domestic violence and perinatal outcomes - a prospective cohort study from Nepal.
    Pun KD; Rishal P; Darj E; Infanti JJ; Shrestha S; Lukasse M; Schei B;
    BMC Public Health; 2019 May; 19(1):671. PubMed ID: 31151395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.